Our findings suggest that MS17 upregulated HSPPA9, LCP1 and MSN and downregulated TALDO1 in SW620 cells, which could affect the JAK-STAT signaling pathway and associated with apoptosis, proliferation, and immune response, resulting in anti-cancer effects. Here, MSN is linked to cancer.